Device-tax repeal will keep U.S. edge in global medtech, exec says

03/27/2013 | Hill, The

The industry already has paid the IRS about $388 million since the 2.3% medical device tax went into effect in January, shifting funds that could otherwise be used to create jobs and advance research and development, writes Siemens Healthcare CEO Greg Sorensen in this article. The passage of the Senate budget amendment to repeal the tax is a key step toward reversing its adverse effects and preserving U.S. leadership in the global medtech industry, he writes.

View Full Article in:

Hill, The

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Executive Officer
Center for Improving Value in Healthcare
Denver, CO
Quality Program Manager II, State Programs
Tufts Health Plan
Watertown, MA
Associate Director, Promotion Integrity
Bristol-Myers Squibb
Plainsboro, NJ
Vice President, Medicare Advantage
BCBS-Louisiana
Baton Rouge, LA
Director, Global Integrity and Compliance, Pharmaceuticals
Alcon
Fort Worth, TX